1. Market Research
  2. > Pharmaceutical Market Trends
  3. > United Kingdom Pharmaceuticals and Healthcare Report Q2 2016

United Kingdom Pharmaceuticals and Healthcare Report Q2 2016

  • April 2016
  • -
  • Business Monitor International
  • -
  • 106 pages

Includes 3 FREE quarterly updates

BMI View: Although we retain our view that the UK will remain a member of the European Union after theBrexit referendum to be held on June 23, uncertainty over the outcome increased in the first months of2016, and a Brexit would pose significant challenges to the UK and European pharmaceutical industries.The negative implications of a Brexit for the drug industry would include a reduction of scientific funding inthe UK, a decrease in patient access to innovative medicines, an increase in market access barriers tomultinational drugmakers and delays in the approvals of medicines. Although the UK government's recentdecision to strengthen healthcare expenditure over the next few years is in line with our view of continuedgrowth and rising demand in the sector, the potential effects of a Brexit on the economy pose downside risksto our pharmaceuticals and healthcare sector forecasts.

Headline Expenditure Projections

- Pharmaceuticals: GBP26.20bn (USD40.04bn) in 2015 to GBP26.80bn (USD38.29bn) in 2016; +2.3%in local currency terms and -4.4% in US dollar terms. Forecast revised upwards from last quarter.

- Healthcare: GBP155.16bn (USD237.11bn) in 2015 to GBP159.87bn (USD228.38bn) in 2016; +3.0% inlocal currency terms and -3.7% in US dollar terms. Forecast revised broadly in line with last quarter.

Table Of Contents

United Kingdom Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (United Kingdom 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (United Kingdom 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (United Kingdom 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (United Kingdom 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (United Kingdom 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (United Kingdom 2012-2020) 21
Patented Drug Market Forecast 22
Table: Patented Drug Market Indicators, Historical Data And Forecasts (United Kingdom 2012-2020) 24
Generic Drug Market Forecast 25
OTC Medicine Market Forecast 28
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (United Kingdom 2012-2020) 30
Pharmaceutical Trade Forecast 31
Table: Pharmaceutical Trade Data And Forecasts (United Kingdom 2014-2020) 33
Table: Pharmaceutical Trade Data And Forecasts local currency (United Kingdom 2014-2020) 33
Industry Risk Reward Indices 34
Western Europe Risk/Reward Index 34
United Kingdom Risk/Reward Index 39
Rewards 39
Risks 40
Regulatory Review 41
Intellectual Property Issues 43
Pricing Regime 45
Reimbursement Regime 51
Market Overview 54
Healthcare Sector 55
Table: Healthcare Resources (United Kingdom 2010-2015) 60
Table: Healthcare Personnel (United Kingdom 2010-2015) 60
Table: Healthcare Activity (United Kingdom 2010-2015) 61
Research And Development 61
Clinical Trials 63
Epidemiology 64
Competitive Landscape 67
Research-Based Industry 67
Table: Leading Pharmaceutical Corporations' UK market share, 2014 67
Table: Multinational Market Activity 70
Pharmaceutical Distribution 71
Pharmaceutical Retail Sector 72
Table: UK-Registered Retail Pharmacies, 2010 73
Company Profile 74
GlaxoSmithKline 74
AstraZeneca 80
Pfizer 86
Novartis 89
Sanofi 92
Demographic Forecast 95
Table: Population Headline Indicators (United Kingdom 1990-2025) 96
Table: Key Population Ratios (United Kingdom 1990-2025) 96
Table: Urban/Rural Population and Life Expectancy (United Kingdom 1990-2025) 97
Table: Population By Age Group (United Kingdom 1990-2025) 97
Table: Population By Age Group % (United Kingdom 1990-2025) 98
Glossary 100
Methodology 102
Pharmaceutical Expenditure Forecast Model 102
Healthcare Expenditure Forecast Model 102
Notes On Methodology 103
Risk/Reward Index Methodology 104
Index Overview 105
Table: Pharmaceutical Risk/Reward Index Indicators 105
Indicator Weightings 106

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.